Capital One National Association’s Biogen BIIB Stock Holding History

Capital One National Association’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$5.51M	Sell	18,999 -291	-2%	-$81.8K	0.4%	59
2018 Q1	$5.28M	Sell	19,290 -4,730	-20%	-$1.47M	0.37%	63
2017 Q4	$7.65M	Sell	24,020 -945	-4%	-$303K	0.52%	46
2017 Q3	$7.82M	Buy	24,965 +1,489	+6%	+$441K	0.55%	41
2017 Q2	$6.37M	Sell	23,476 -855	-4%	-$226K	0.46%	54
2017 Q1	$6.65M	Sell	24,331 -791	-3%	-$224K	0.5%	45
2016 Q4	$7.12M	Sell	25,122 -132	-0.5%	-$39.1K	0.53%	39
2016 Q3	$7.91M	Buy	25,254 +8,825	+54%	+$2.61M	0.63%	38
2016 Q2	$3.97M	Buy	16,429 +2,620	+19%	+$690K	0.33%	77
2016 Q1	$3.6M	Buy	13,809 +123	+0.9%	+$32.5K	0.33%	80
2015 Q4	$4.19M	Buy	13,686 +1,371	+11%	+$394K	0.36%	73
2015 Q3	$3.59M	Buy	12,315 +444	+4%	+$147K	0.35%	80
2015 Q2	$4.79M	Buy	11,871 +233	+2%	+$93.5K	0.43%	62
2015 Q1	$4.91M	Sell	11,638 -63	-0.5%	-$24.8K	0.44%	63
2014 Q4	$3.97M	Sell	11,701 -1,223	-9%	-$396K	0.38%	70
2014 Q3	$4.28M	Sell	12,924 -226	-2%	-$74.5K	0.42%	64
2014 Q2	$4.15M	Sell	13,150 -292	-2%	-$87.9K	0.39%	74
2014 Q1	$4.11M	Sell	13,442 -103	-0.8%	-$32.7K	0.4%	71
2013 Q4	$3.79M	Buy	13,545 +1,335	+11%	+$345K	0.37%	75
2013 Q3	$2.94M	Buy	12,210 +630	+5%	+$141K	0.3%	97
2013 Q2	$2.49M	Buy	+11,580	New	+$2.47M	0.27%	110

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital One National Association's BIIB Position: Q2 2018 in Review

Capital One National Association reduced its Biogen (BIIB) stake by 1.5% in Q2 2018, selling an estimated $81.8K and leaving 18,999 shares worth $5.51M. The position accounts for 0.4% of the portfolio, ranked #59.

Capital One National Association first reported a position in BIIB in Q2 2013 and has held it in 21 quarters since. The position peaked at $7.91M in Q3 2016. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

Capital One National Association held 18,999 shares of Biogen worth $5.51M as of Q2 2018.
Capital One National Association sold 291 Biogen shares in Q2 2018, an estimated $81.8K.
Biogen made up 0.4% of Capital One National Association's portfolio in Q2 2018, its #59 holding.
Capital One National Association first reported a position in Biogen in Q2 2013 and has held it in 21 quarters since.
Capital One National Association's Biogen position peaked at $7.91M in Q3 2016.
1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.